JP2000513361A - オレアミドヒドロラーゼ阻害剤 - Google Patents
オレアミドヒドロラーゼ阻害剤Info
- Publication number
- JP2000513361A JP2000513361A JP10503557A JP50355798A JP2000513361A JP 2000513361 A JP2000513361 A JP 2000513361A JP 10503557 A JP10503557 A JP 10503557A JP 50355798 A JP50355798 A JP 50355798A JP 2000513361 A JP2000513361 A JP 2000513361A
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- represented
- following structure
- oleamide
- oleamide hydrolase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/30—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/12—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom
- C07C245/14—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/21—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/227—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.先端基及び前記先端基に共有結合した炭化水素末端基を含むオレアミドヒド ロラーゼ阻害剤であって、前記先端基が求電子カルボニルを含みかつ下記構造 : で表される基からなる群より選ばれ、前記炭化水素末端基が下記構造: で表される基からなる群より選ばれる、前記オレアミドヒドロラーゼ阻害剤。 2.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 3.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。4.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 5.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 6.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 7.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 8.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 9.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。10.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 11.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 12.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 12.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 13.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 14.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。15.下記構造で表される、請求項1記載のオレアミドヒドロラーゼ阻害剤。 16.先端基及び前記先端基に共有結合した炭化水素末端基を含む阻害剤と接触さ せることによるオレアミドヒドロラーゼの阻害方法であって、前記先端基が求 電子カルボニルを含みかつ下記構造: で表される基からなる群より選ばれ、前記炭化水素末端基が下記構造: で表される基からなる群より選ばれる、前記オレアミドヒドロラーゼの阻害方 法。 17.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラー ゼの阻害方法。 18.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラー ゼの阻害方法。 19.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 20.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。21.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 22.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 23.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 24.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 25.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 26.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 27.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 28.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 29.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 30.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。31.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 32.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 33.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 34.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 35.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 36.前記阻害剤が下記構造で表される、請求項16記載のオレアミドヒドロラーゼ の阻害方法。 37.オレアミド感受性動物体内で睡眠を誘発する方法であって、下記構造で表さ れるオレアミドヒドロラーゼアゴニストを該オレアミド感受性動物に投与する 、前記方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/670,284 US5856537A (en) | 1996-06-26 | 1996-06-26 | Inhibitors of oleamide hydrolase |
US08/670,284 | 1996-06-26 | ||
PCT/US1997/011213 WO1997049667A1 (en) | 1996-06-26 | 1997-06-26 | Inhibitors of oleamide hydrolase |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2000513361A true JP2000513361A (ja) | 2000-10-10 |
JP2000513361A5 JP2000513361A5 (ja) | 2004-12-09 |
JP4184435B2 JP4184435B2 (ja) | 2008-11-19 |
Family
ID=24689784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50355798A Expired - Fee Related JP4184435B2 (ja) | 1996-06-26 | 1997-06-26 | オレアミドヒドロラーゼ阻害剤 |
Country Status (8)
Country | Link |
---|---|
US (2) | US5856537A (ja) |
EP (1) | EP0910561B1 (ja) |
JP (1) | JP4184435B2 (ja) |
CN (2) | CN101156840A (ja) |
AT (1) | ATE263751T1 (ja) |
AU (1) | AU734477B2 (ja) |
DE (1) | DE69728537T2 (ja) |
WO (1) | WO1997049667A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005527479A (ja) * | 2001-10-11 | 2005-09-15 | ユニベルシタト デ レス イルレス バレアルス | 医薬品の製造におけるヒドロキシオレイン酸及び類似化合物の使用 |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001523695A (ja) * | 1997-11-24 | 2001-11-27 | ザ スクリップス リサーチ インスティテュート | ギャップ結合連絡の阻害剤 |
US6858649B1 (en) * | 1998-04-30 | 2005-02-22 | The Scripps Research Institute | Selective potentiation of serotonin receptor subtypes |
GB9926833D0 (en) * | 1999-11-15 | 2000-01-12 | Univ Sunderland | Compositions |
CA2437353A1 (en) * | 2001-02-08 | 2002-08-15 | Nps Pharmaceuticals, Inc. | Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
AU2002338329B2 (en) | 2001-03-27 | 2006-09-07 | The Regents Of The University Of California | Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
US20050054730A1 (en) * | 2001-03-27 | 2005-03-10 | The Regents Of The University Of California | Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha |
CA2455555A1 (en) * | 2001-07-31 | 2003-02-13 | The Scripps Research Institute | Animal model for fatty acid amide-related neurobehaviors |
US20040063726A1 (en) * | 2002-02-08 | 2004-04-01 | Artman Linda D | Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
UA80841C2 (en) * | 2002-10-07 | 2007-11-12 | Univ California | Fatty acid amide hydrolase inhibitors, pharmaceutical composition (variants) and method to treat appetite disorders, glaucoma, pain, and related neurological disorders (variants) |
US7765162B2 (en) * | 2002-10-07 | 2010-07-27 | Mastercard International Incorporated | Method and system for conducting off-line and on-line pre-authorized payment transactions |
CA2542547A1 (en) * | 2003-10-16 | 2005-05-26 | Daniele Piomelli | Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism |
HUE033441T2 (en) | 2004-12-30 | 2017-11-28 | Janssen Pharmaceutica Nv | 4- (Benzyl) piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid hydrolase (phaha) for the treatment of anxiety, pain and other diseases |
WO2006116773A2 (en) * | 2005-04-28 | 2006-11-02 | The Regents Of The University Of California | Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders |
PE20070099A1 (es) | 2005-06-30 | 2007-02-06 | Janssen Pharmaceutica Nv | N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso |
WO2007061862A2 (en) | 2005-11-18 | 2007-05-31 | Janssen Pharmaceutica N.V. | 2-keto-oxazoles as modulators of fatty acid amide hydrolase |
US7915270B2 (en) | 2006-02-17 | 2011-03-29 | The Scripps Research Institute | Oxazole ketones as modulators of fatty acid amide hydrolase |
US20100292266A1 (en) * | 2006-05-26 | 2010-11-18 | Richard Apodaca | Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase |
WO2008030752A2 (en) * | 2006-09-07 | 2008-03-13 | N.V. Organon | Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo |
JO3598B1 (ar) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
WO2008063714A1 (en) * | 2006-11-20 | 2008-05-29 | N.V. Organon | Metabolically-stabilized inhibitors of fatty acid amide hydrolase |
CA2721060A1 (en) * | 2008-04-09 | 2009-10-15 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
ES2342997B1 (es) | 2008-12-09 | 2011-06-06 | Universitat De Les Illes Balears | Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento. |
WO2010118159A1 (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
EP2416660B1 (en) | 2009-04-07 | 2014-07-02 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
US9062116B2 (en) | 2009-04-23 | 2015-06-23 | Infinity Pharmaceuticals, Inc. | Anti-fatty acid amide hydrolase-2 antibodies and uses thereof |
US8765735B2 (en) * | 2009-05-18 | 2014-07-01 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
US9149465B2 (en) * | 2009-05-18 | 2015-10-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
US8927551B2 (en) * | 2009-05-18 | 2015-01-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
US20120225097A1 (en) | 2009-11-12 | 2012-09-06 | Hawryluk Natalie A | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
CA2788587C (en) | 2010-02-03 | 2020-03-10 | Infinity Pharmaceuticals, Inc. | Fatty acid amide hydrolase inhibitors |
UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
WO2017066211A1 (en) | 2015-10-12 | 2017-04-20 | Advanced Cell Diagnostics, Inc. | In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto |
US20230023267A1 (en) * | 2019-11-12 | 2023-01-26 | The Trustees Of The University Of Pennsylvania | Oleic acid derivatives as treatments for friedreich ataxia and inhibitors of ferroptosis |
CN111004125B (zh) * | 2019-12-24 | 2022-11-22 | 东华理工大学 | 一种缩醛或缩酮化合物的制备方法 |
BR112022015172A2 (pt) | 2020-01-29 | 2022-10-11 | Univ Illes Balears | Metabólitos de ácidos graxos alfa-hidroxilados, usos médicos dos mesmos e uso como biomarcadores |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4493848A (en) * | 1983-07-14 | 1985-01-15 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
JPH0789937B2 (ja) * | 1987-09-29 | 1995-10-04 | 塩野香料株式会社 | 海藻の酵素を利用した不飽和アルデヒドの生産 |
-
1996
- 1996-06-26 US US08/670,284 patent/US5856537A/en not_active Expired - Fee Related
-
1997
- 1997-06-26 AT AT97931457T patent/ATE263751T1/de not_active IP Right Cessation
- 1997-06-26 DE DE69728537T patent/DE69728537T2/de not_active Expired - Fee Related
- 1997-06-26 CN CNA200710166760XA patent/CN101156840A/zh active Pending
- 1997-06-26 AU AU35082/97A patent/AU734477B2/en not_active Ceased
- 1997-06-26 JP JP50355798A patent/JP4184435B2/ja not_active Expired - Fee Related
- 1997-06-26 WO PCT/US1997/011213 patent/WO1997049667A1/en active IP Right Grant
- 1997-06-26 CN CNB971974314A patent/CN100369887C/zh not_active Expired - Fee Related
- 1997-06-26 EP EP97931457A patent/EP0910561B1/en not_active Expired - Lifetime
-
1999
- 1999-01-05 US US09/225,428 patent/US6096784A/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005527479A (ja) * | 2001-10-11 | 2005-09-15 | ユニベルシタト デ レス イルレス バレアルス | 医薬品の製造におけるヒドロキシオレイン酸及び類似化合物の使用 |
JP4737931B2 (ja) * | 2001-10-11 | 2011-08-03 | ユニベルシタト デ レス イルレス バレアルス | 医薬品の製造におけるヒドロキシオレイン酸及び類似化合物の使用 |
Also Published As
Publication number | Publication date |
---|---|
DE69728537D1 (de) | 2004-05-13 |
CN1228764A (zh) | 1999-09-15 |
EP0910561A4 (en) | 2000-06-07 |
US6096784A (en) | 2000-08-01 |
CN100369887C (zh) | 2008-02-20 |
EP0910561A1 (en) | 1999-04-28 |
JP4184435B2 (ja) | 2008-11-19 |
AU734477B2 (en) | 2001-06-14 |
US5856537A (en) | 1999-01-05 |
WO1997049667A1 (en) | 1997-12-31 |
DE69728537T2 (de) | 2005-03-24 |
CN101156840A (zh) | 2008-04-09 |
AU3508297A (en) | 1998-01-14 |
EP0910561B1 (en) | 2004-04-07 |
ATE263751T1 (de) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000513361A (ja) | オレアミドヒドロラーゼ阻害剤 | |
CA2102454C (fr) | Derives de l'erythromycine, leur procede de preparation, leur application comme medicaments | |
CA2290520C (en) | Inhibition of p38 kinase activity by aryl ureas | |
JPH11507912A (ja) | システインプロテアーゼインヒビターとしてのα−(1,3−ジカルボニルエノールエーテル)メチルケトン | |
US20100160371A1 (en) | Inhibition of p38 kinase activity by aryl ureas | |
CA1319682C (fr) | Procede de preparation de nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique | |
CH633292A5 (fr) | Oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, procede de preparation et compositions pharmaceutiques. | |
CN103772312A (zh) | 抗炎症的2-羰基噻唑和2-羰基恶唑 | |
WO2010017132A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
EP1673337A2 (fr) | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique sanofi-synthelabo | |
FR2482596A1 (fr) | Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament | |
JP2022516195A (ja) | ヒドロキサム酸誘導体並びその調製方法及び使用 | |
CH617204A5 (ja) | ||
CA2112866C (fr) | Nouveaux derives 2-cyano 3-hydroxy propenamides, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
Mehta et al. | Synthesis, pharmacological and toxicological evaluation of amide derivatives of ibuprofen | |
Kim et al. | Fully stereocontrolled syntheses of 3-oxacarbacyclin and carbacyclin by the conjugate addition-azoalkene-asymmetric olefination strategy | |
Lubisch et al. | Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors | |
CA1132537A (fr) | Procede de preparation de nouvelles oximes derivees de l'acide 3-thiadiazolyl thiomethyl 7-aminothiazolyl acetamido cephalosporanique | |
CA2258764C (en) | Inhibitors of oleamide hydrolase | |
FR2597865A1 (fr) | Nouveaux derives d'un acide benzyl alkyl carboxylique substitue par un radical 4-pyridinyl aminocarbonyle, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant | |
FR2749585A1 (fr) | Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments | |
CH618177A5 (ja) | ||
JPH06504984A (ja) | 新規ロイコトリエン―b4―拮抗物質、その製法及びその医薬としての使用 | |
JPH04368359A (ja) | カプサイシン誘導体又はその酸エステルを有効成分とする鎮痛剤、血管拡張剤 | |
EP0761672B1 (fr) | Nouvelles céphalosporines comportant en position 7 un radical benzyloxyimino substitué, leurs procédés et intermédiaires de préparation, leur application comme médicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040408 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040408 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071218 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080318 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080428 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080618 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080805 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080904 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110912 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |